Whole Brain Radiotherapy and RRx-001: Two Partial Responses in Radioresistant Melanoma Brain Metastases from a Phase I/II Clinical Trial()(): A TITE-CRM Phase I/II Clinical Trial

BACKGROUND: Kim et al. report two patients with melanoma metastases to the brain that responded to treatment with RRx-001 and whole brain radiotherapy (WBRT) without neurologic or systemic toxicity in the context of a phase I/II clinical trial. RRx-001 is an reactive oxygen and reactive nitrogen spe...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Transl Oncol
Egile Nagusiak: Kim, Michelle M., Parmar, Hemant, Cao, Yue, Pramanik, Priyanka, Schipper, Matthew, Hayman, James, Junck, Larry, Mammoser, Aaron, Heth, Jason, Carter, Corey A., Oronsky, Arnold, Knox, Susan J., Caroen, Scott, Oronsky, Bryan, Scicinski, Jan, Lawrence, Theodore S., Lao, Christopher D.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Neoplasia Press 2016
Gaiak:
Original article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4833892/
https://ncbi.nlm.nih.gov/pubmed/27084426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2015.12.003
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak